TIRZEPATIDE (Mounjaro®)
Clinical Indication
For treating type 2 diabetes
Comments
As per NICE TA924
Date of classification
December 2023
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .